C. Ryan Miller

Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: a sensitive method for assessing 5-fluorocytosine toxicity in vitro.

Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.

Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation.

Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization.

Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.

Pharmacogenomics of cancer chemotherapy-induced toxicity.

Glioblastoma.

A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancer.

Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.

Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients.

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types.

Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease.

Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade.

The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.

Genetically engineered mouse models of diffuse gliomas.

High XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinoma.

Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases.

RhoGDI2 antagonizes ovarian carcinoma growth, invasion and metastasis.

An animal model of MYC-driven medulloblastoma.

Validation of Interobserver Agreement in Lung Cancer Assessment Hematoxylin-Eosin Diagnostic Reproducibility for Non-Small Cell Lung Cancer-The 2004 World Health Organization Classification and Therapeutically Relevant Subsets.

Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation.

LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.

Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis.

Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer.

Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system.

HIF1α and HIF2α independently activate SRC to promote melanoma metastases.

MERTK receptor tyrosine kinase is a therapeutic target in melanoma.

Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer.

Prediction of lung cancer histological types by RT-qPCR gene expression in FFPE specimens.

Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis.

Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.

Hexokinase-2-mediated aerobic glycolysis is integral to cerebellar neurogenesis and pathogenesis of medulloblastoma.

Evolutionary etiology of high-grade astrocytomas.

αB-crystallin: a novel regulator of breast cancer metastasis to the brain.

Cerebellar granule neuron progenitors are the source of Hk2 in the postnatal cerebellum.

Hexokinase-2-mediated aerobic glycolysis is integral to cerebellar neurogenesis and pathogenesis of medulloblastoma.

Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop.

Development of DNA damage response signaling biomarkers using automated, quantitative image analysis.

The Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation.

Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal.

ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.